Silverfin false false 31/12/2025 01/01/2025 31/12/2025 Nicole Sturzenbaum 20/08/2013 Stephen Sturzenbaum 29/09/2017 20 March 2026 Dental practice activities 08658041 2025-12-31 08658041 bus:Director1 2025-12-31 08658041 bus:Director2 2025-12-31 08658041 2024-12-31 08658041 core:CurrentFinancialInstruments 2025-12-31 08658041 core:CurrentFinancialInstruments 2024-12-31 08658041 core:Non-currentFinancialInstruments 2025-12-31 08658041 core:Non-currentFinancialInstruments 2024-12-31 08658041 core:ShareCapital 2025-12-31 08658041 core:ShareCapital 2024-12-31 08658041 core:RetainedEarningsAccumulatedLosses 2025-12-31 08658041 core:RetainedEarningsAccumulatedLosses 2024-12-31 08658041 core:Goodwill 2024-12-31 08658041 core:PatentsTrademarksLicencesConcessionsSimilar 2024-12-31 08658041 core:Goodwill 2025-12-31 08658041 core:PatentsTrademarksLicencesConcessionsSimilar 2025-12-31 08658041 core:LeaseholdImprovements 2024-12-31 08658041 core:PlantMachinery 2024-12-31 08658041 core:FurnitureFittings 2024-12-31 08658041 core:ComputerEquipment 2024-12-31 08658041 core:LeaseholdImprovements 2025-12-31 08658041 core:PlantMachinery 2025-12-31 08658041 core:FurnitureFittings 2025-12-31 08658041 core:ComputerEquipment 2025-12-31 08658041 2023-12-31 08658041 bus:OrdinaryShareClass1 2025-12-31 08658041 bus:OrdinaryShareClass2 2025-12-31 08658041 2025-01-01 2025-12-31 08658041 bus:FilletedAccounts 2025-01-01 2025-12-31 08658041 bus:SmallEntities 2025-01-01 2025-12-31 08658041 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 08658041 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 08658041 bus:Director1 2025-01-01 2025-12-31 08658041 bus:Director2 2025-01-01 2025-12-31 08658041 core:Goodwill core:TopRangeValue 2025-01-01 2025-12-31 08658041 core:PatentsTrademarksLicencesConcessionsSimilar core:TopRangeValue 2025-01-01 2025-12-31 08658041 core:LeaseholdImprovements core:TopRangeValue 2025-01-01 2025-12-31 08658041 core:PlantMachinery 2025-01-01 2025-12-31 08658041 core:PlantMachinery core:TopRangeValue 2025-01-01 2025-12-31 08658041 core:FurnitureFittings 2025-01-01 2025-12-31 08658041 core:FurnitureFittings core:TopRangeValue 2025-01-01 2025-12-31 08658041 core:ComputerEquipment core:TopRangeValue 2025-01-01 2025-12-31 08658041 2024-01-01 2024-12-31 08658041 core:Goodwill 2025-01-01 2025-12-31 08658041 core:PatentsTrademarksLicencesConcessionsSimilar 2025-01-01 2025-12-31 08658041 core:LeaseholdImprovements 2025-01-01 2025-12-31 08658041 core:ComputerEquipment 2025-01-01 2025-12-31 08658041 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 08658041 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 08658041 bus:OrdinaryShareClass2 2025-01-01 2025-12-31 08658041 bus:OrdinaryShareClass2 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 08658041 (England and Wales)

CARE4MILKTEETH LIMITED

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH THE REGISTRAR

CARE4MILKTEETH LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2025

Contents

CARE4MILKTEETH LIMITED

COMPANY INFORMATION

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2025
CARE4MILKTEETH LIMITED

COMPANY INFORMATION (continued)

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2025
DIRECTORS Nicole Sturzenbaum
Stephen Sturzenbaum
REGISTERED OFFICE Wey Court West
Union Road
Farnham
Surrey
United Kingdom
GU9 7PT
United Kingdom
COMPANY NUMBER 08658041 (England and Wales)
ACCOUNTANT Shaw Gibbs Limited
Wey Court West
Union Road
Farnham
Surrey
GU9 7PT
CARE4MILKTEETH LIMITED

BALANCE SHEET

AS AT 31 DECEMBER 2025
CARE4MILKTEETH LIMITED

BALANCE SHEET (continued)

AS AT 31 DECEMBER 2025
Note 31.12.2025 31.12.2024
£ £
Fixed assets
Intangible assets 3 237,250 373,250
Tangible assets 4 110,312 154,812
347,562 528,062
Current assets
Stocks 5 181,262 100,000
Debtors 6 503,788 111,872
Cash at bank and in hand 7 114,670 36,536
799,720 248,408
Creditors: amounts falling due within one year 8 ( 669,234) ( 633,638)
Net current assets/(liabilities) 130,486 (385,230)
Total assets less current liabilities 478,048 142,832
Creditors: amounts falling due after more than one year 9, 13 0 ( 14,000)
Provision for liabilities 10, 11 ( 19,279) ( 28,141)
Net assets 458,769 100,691
Capital and reserves
Called-up share capital 12 1 1
Profit and loss account 458,768 100,690
Total shareholders' funds 458,769 100,691

For the financial year ending 31 December 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of CARE4MILKTEETH LIMITED (registered number: 08658041) were approved and authorised for issue by the Board of Directors on 20 March 2026. They were signed on its behalf by:

Nicole Sturzenbaum
Director
CARE4MILKTEETH LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2025
CARE4MILKTEETH LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

CARE4MILKTEETH LIMITED (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Wey Court West, Union Road, Farnham, Surrey, United Kingdom, GU9 7PT, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover represents income from the provision of dental and orthodontic services supplied by
the company. Turnover is adjusted to reflect the the degree of completion of work carried out.

Taxation

Current tax
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Goodwill 10 years straight line
Trademarks, patents and licences 10 years straight line
Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Leasehold improvements 10 years straight line
Plant and machinery 20 % reducing balance
5 years straight line
Fixtures and fittings 20 % reducing balance
5 years straight line
Computer equipment 5 years straight line

Depreciation methods, useful lives and residual values are reviewed at each balance sheet date. The selection of these residual values and estimated lives requires the exercise of judgement. The directors are required to assess whether there is an indication of impairment to the carrying value of assets. In making that assessment, judgements are made in estimating value in use. The directors consider that the individual carrying values of assets are supportable by their value in use.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Leases

The Company as lessee
Assets held under finance leases, hire purchase contracts and other similar arrangements, which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or, if lower, the present value of the minimum lease payments as determined at the inception of the lease) and are depreciated over the shorter of the lease terms and their useful lives. The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the Profit and Loss Account over the period of the leases to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

2. Employees

31.12.2025 31.12.2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 26 27

3. Intangible assets

Goodwill Trademarks, patents
and licences
Total
£ £ £
Cost
At 01 January 2025 1,350,000 10,000 1,360,000
At 31 December 2025 1,350,000 10,000 1,360,000
Accumulated amortisation
At 01 January 2025 978,750 8,000 986,750
Charge for the financial year 135,000 1,000 136,000
At 31 December 2025 1,113,750 9,000 1,122,750
Net book value
At 31 December 2025 236,250 1,000 237,250
At 31 December 2024 371,250 2,000 373,250

4. Tangible assets

Leasehold improve-
ments
Plant and machinery Fixtures and fittings Computer equipment Total
£ £ £ £ £
Cost
At 01 January 2025 28,771 224,494 103,082 88,683 445,030
Additions 0 13,061 12,767 5,116 30,944
At 31 December 2025 28,771 237,555 115,849 93,799 475,974
Accumulated depreciation
At 01 January 2025 20,859 151,086 56,996 61,277 290,218
Charge for the financial year 2,877 40,592 21,598 10,377 75,444
At 31 December 2025 23,736 191,678 78,594 71,654 365,662
Net book value
At 31 December 2025 5,035 45,877 37,255 22,145 110,312
At 31 December 2024 7,912 73,408 46,086 27,406 154,812

5. Stocks

31.12.2025 31.12.2024
£ £
Stocks 181,262 100,000

6. Debtors

31.12.2025 31.12.2024
£ £
Trade debtors 57,466 51,964
Amounts owed by directors 383,540 1,924
Prepayments 62,132 56,974
Other debtors 650 1,010
503,788 111,872

7. Cash and cash equivalents

31.12.2025 31.12.2024
£ £
Cash at bank and in hand ( 1,565) 3,463
Short-term deposits 116,235 33,073
114,670 36,536

8. Creditors: amounts falling due within one year

31.12.2025 31.12.2024
£ £
Bank loans 14,000 48,000
Trade creditors 157,608 130,946
Accruals 102,438 79,630
Corporation tax 324,710 310,404
Other taxation and social security 24,454 24,850
Other creditors 46,024 39,808
669,234 633,638

9. Creditors: amounts falling due after more than one year

31.12.2025 31.12.2024
£ £
Bank loans 0 14,000

10. Provision for liabilities

31.12.2025 31.12.2024
£ £
Deferred tax 19,279 28,141

11. Deferred tax

31.12.2025 31.12.2024
£ £
At the beginning of financial year ( 28,141) ( 28,562)
Credited to the Profit and Loss Account 8,862 421
At the end of financial year ( 19,279) ( 28,141)

12. Called-up share capital

31.12.2025 31.12.2024
£ £
Allotted, called-up and fully-paid
80 A ordinary shares of £ 0.01 each 0.80 0.80
20 B ordinary shares of £ 0.01 each 0.20 0.20
1.00 1.00

13. Leasing agreements

Non-cancellable operating leases

31.12.2025 31.12.2024
£ £
Within one year 144,000 144,000
Between one and five years 576,000 576,000
In more than five years 1,008,000 1,152,000
1,728,000 1,872,000

14. Ultimate controlling party

The controlling party is Dr N Sturzenbaum.